Wells Fargo
SRNE

Wells Fargo’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Wells Fargo’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,039,799
Closed -$921K – 7884
2022
Q4 		$921K Sell
1,039,799
-280,793
-21% -$372K ﹤0.01% 3290
2022
Q3 		$2.07M Buy
1,320,592
+214,036
+19% +$486K ﹤0.01% 2712
2022
Q2 		$2.23M Sell
1,106,556
-232,630
-17% -$402K ﹤0.01% 2702
2022
Q1 		$3.12M Buy
1,339,186
+172,823
+15% +$539K ﹤0.01% 2880
2021
Q4 		$5.42M Buy
1,166,363
+240,918
+26% +$1.5M ﹤0.01% 2490
2021
Q3 		$7.06M Buy
925,445
+98,912
+12% +$839K ﹤0.01% 2523
2021
Q2 		$8.01M Buy
826,533
+29,683
+4% +$236K ﹤0.01% 2423
2021
Q1 		$6.59M Sell
796,850
-223,713
-22% -$2.36M ﹤0.01% 2567
2020
Q4 		$6.96M Buy
1,020,563
+253,959
+33% +$2.04M ﹤0.01% 2421
2020
Q3 		$8.55M Buy
766,604
+164,111
+27% +$1.5M ﹤0.01% 2006
2020
Q2 		$3.78M Buy
602,493
+532,025
+755% +$2.04M ﹤0.01% 2744
2020
Q1 		$130K Sell
70,468
-73,180
-51% -$211K ﹤0.01% 4930
2019
Q4 		$485K Buy
143,648
+24,766
+21% +$59K ﹤0.01% 4399
2019
Q3 		$254K Buy
118,882
+3,342
+3% +$7.79K ﹤0.01% 4818
2019
Q2 		$308K Sell
115,540
-92,663
-45% -$333K ﹤0.01% 4711
2019
Q1 		$988K Buy
208,203
+26,969
+15% +$70.8K ﹤0.01% 3886
2018
Q4 		$435K Buy
181,234
+27,317
+18% +$89.2K ﹤0.01% 4419
2018
Q3 		$677K Sell
153,917
-458,051
-75% -$2.54M ﹤0.01% 4238
2018
Q2 		$4.41M Buy
611,968
+110,768
+22% +$753K ﹤0.01% 2812
2018
Q1 		$2.58M Buy
501,200
+498,700
+19,948% +$3.55M ﹤0.01% 3180
2017
Q4 		$10K Hold
2,500
– – ﹤0.01% 5929
2017
Q3 		$4K Buy
+2,500
New +$4.59K ﹤0.01% 6087
2017
Q2 		– Sell
-91,593
Closed -$362K – 6561
2017
Q1 		$362K Sell
91,593
-33,668
-27% -$169K ﹤0.01% 4459
2016
Q4 		$614K Buy
125,261
+108,424
+644% +$651K ﹤0.01% 4056
2016
Q3 		$130K Sell
16,837
-1,000
-6% -$6.73K ﹤0.01% 4751
2016
Q2 		$100K Sell
17,837
-4,617
-21% -$29.5K ﹤0.01% 4833
2016
Q1 		$120K Buy
22,454
+2,495
+13% +$14.5K ﹤0.01% 4712
2015
Q4 		$174K Buy
19,959
+290
+1% +$2.45K ﹤0.01% 4544
2015
Q3 		$165K Buy
19,669
+7,248
+58% +$115K ﹤0.01% 4572
2015
Q2 		$219K Sell
12,421
-2,793
-18% -$35.9K ﹤0.01% 4568
2015
Q1 		$176K Buy
15,214
+15,213
+1,521,300% +$176K ﹤0.01% 4476
2014
Q4 		$0 Hold
1
– – ﹤0.01% 6507
2014
Q3 		$0 Hold
1
– – ﹤0.01% 6430
2014
Q2 		$0 Sell
1
-6,297
-100% -$47.5K ﹤0.01% 6370
2014
Q1 		$81K Buy
6,298
+6,297
+629,700% +$69.7K ﹤0.01% 4747
2013
Q4 		$0 Buy
+1
New +$9 ﹤0.01% 6023

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return